Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1α-24, (R)-dihydroxycholecalciferol (tacalcitol) cream

European Journal of Dermatology

Volumn 10, Issue 7, 2000, Pages 528-532

  Nakayama, J ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Sebopsoriasis; Seborrheic dermatitis; Tacalcitol cream; Vitamin D3

Indexed keywords

TACALCITOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ERYTHEMA; FACE; FEMALE; HUMAN; MALE; PSORIASIS VULGARIS; SCALP; SEBORRHEIC DERMATITIS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 0033757222     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Efficacy of TV-02 ointment for psoriasis. Results of double-blind side-by-side clinical comparison with placebo (ointment base)
2. The effect of 1,24 (R) (OH)2D3 cream and ointment on epidermal proliferation and differentiation in mice
3. Treatment of sebopsoriasis. A clinical trial-an etiological approach
4. Once daily treatment with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial
5. The downregulation of interleukin 1 and tumour necrosis factor by topical tacalcitol (1,24(OH)2D3) in psoriasis
6. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)
7. Topical active vitamin D3 analogue, 1,24-dihydroxycholecalciferol, an effective new treatment for facial seborrhoeic dermatitis